Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (unaudited)

v3.19.3
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Operating expenses        
Research and development $ 513,004 $ 67,291 $ 1,522,031 $ 92,291
General and administrative 990,110 978,329 3,267,037 3,284,880
Total operating expenses 1,503,114 1,045,620 4,789,068 3,377,171
Operating loss (1,503,114) (1,045,620) (4,789,068) (3,377,171)
Other expense (income)        
Change in fair value of derivative liabilities 3,126,464 1,050,729 (2,024,660) 1,653,477
Fair value of derivative liabilities in excess of proceeds     322,644 7,174,634
Financing transaction costs       137,192
Loss on extinguishment of secured convertible promissory note - related party       590,392
Interest expense 301,547 0 711,575 37,708
Interest income       (74)
Total other expense (income) 3,428,011 1,050,729 (990,441) 9,593,329
Loss before income taxes (4,931,125) (2,096,349) (3,798,627) (12,970,500)
Provision for income taxes 0 0 1,600 1,642
Net Loss and comprehensive loss $ (4,931,125) $ (2,096,349) $ (3,800,227) $ (12,972,142)
Loss per common share:        
Basic (in dollars per share) $ (0.04) $ (0.02) $ (0.03) $ (0.11)
Diluted (in dollars per share) $ (0.04) $ (0.02) $ (0.03) $ (0.11)
Weighted average shares of common stock outstanding used to compute earnings per share:        
Basic (in shares) 133,001,746 131,445,057 132,885,675 117,434,563
Diluted (in shares) 133,001,746 131,445,057 167,690,989 117,434,563